AGIOS PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
AGIOS PHARMACEUTICALS, INC. (AGIO) had Shares Outstanding (Cover Page) of 59.70 million shares as of 2026-07-24, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-24: Entity Common Stock, Shares Outstanding 59.70M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 59.47M shares.
- 2026-02-06: Entity Common Stock, Shares Outstanding 58.59M shares.
- 2025-10-24: Entity Common Stock, Shares Outstanding 58.31M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-07-24 | 59.70M shares 10-Q · filed 2026-07-30 | |
| 2026-04-24 | 59.47M shares 10-Q · filed 2026-04-29 | |
| 2026-02-06 | 58.59M shares 10-K · filed 2026-02-12 | |
| 2025-10-24 | 58.31M shares 10-Q · filed 2025-10-30 | |
| 2025-07-25 | 58.10M shares 10-Q · filed 2025-07-31 | |
| 2025-04-25 | 57.92M shares 10-Q · filed 2025-05-01 | |
| 2025-02-07 | 57.30M shares 10-K · filed 2025-02-13 | |
| 2024-10-25 | 57.03M shares 10-Q · filed 2024-10-31 | |
| 2024-07-26 | 56.89M shares 10-Q · filed 2024-08-01 | |
| 2024-04-26 | 56.77M shares 10-Q · filed 2024-05-02 | |
| 2024-02-09 | 56.19M shares 10-K · filed 2024-02-15 | |
| 2023-10-27 | 55.89M shares 10-Q · filed 2023-11-02 | |
| 2023-07-28 | 55.74M shares 10-Q · filed 2023-08-03 | |
| 2023-04-28 | 55.58M shares 10-Q · filed 2023-05-04 | |
| 2023-02-17 | 55.29M shares 10-K · filed 2023-02-23 | |
| 2022-10-28 | 54.94M shares 10-Q · filed 2022-11-03 | |
| 2022-07-29 | 54.82M shares 10-Q · filed 2022-08-04 | |
| 2022-04-29 | 54.79M shares 10-Q · filed 2022-05-05 | |
| 2022-02-18 | 54.64M shares 10-K · filed 2022-02-24 | |
| 2021-10-29 | 54.31M shares 10-Q · filed 2021-11-03 | |
| 2021-07-23 | 58.95M shares 10-Q · filed 2021-07-29 | |
| 2021-04-23 | 61.57M shares 10-Q/A · filed 2021-05-07 | 69.94M shares 10-Q · filed 2021-04-29 |
| 2021-02-18 | 69.60M shares 10-K · filed 2021-02-25 | |
| 2020-10-30 | 69.26M shares 10-Q · filed 2020-11-05 | |
| 2020-07-24 | 69.11M shares 10-Q · filed 2020-07-30 | |
| 2020-04-24 | 68.89M shares 10-Q · filed 2020-04-30 | |
| 2020-02-13 | 68.51M shares 10-K · filed 2020-02-19 | |
| 2019-10-25 | 58.88M shares 10-Q · filed 2019-10-31 | |
| 2019-07-26 | 58.75M shares 10-Q · filed 2019-08-01 | |
| 2019-04-26 | 58.71M shares 10-Q · filed 2019-05-02 | |
| 2019-02-08 | 58.40M shares 10-K · filed 2019-02-14 | |
| 2018-10-29 | 58.18M shares 10-Q · filed 2018-11-01 | |
| 2018-07-30 | 57.99M shares 10-Q · filed 2018-08-02 | |
| 2018-04-30 | 57.61M shares 10-Q · filed 2018-05-04 | |
| 2018-02-09 | 57.33M shares 10-K · filed 2018-02-14 | |
| 2017-10-30 | 48.75M shares 10-Q · filed 2017-11-01 | |
| 2017-08-04 | 48.39M shares 10-Q · filed 2017-08-08 | |
| 2017-05-01 | 48.20M shares 10-Q · filed 2017-05-04 | |
| 2017-02-14 | 42.23M shares 10-K · filed 2017-02-16 | |
| 2016-10-31 | 42.01M shares 10-Q · filed 2016-11-03 | |
| 2016-08-05 | 38.05M shares 10-Q · filed 2016-08-08 | |
| 2016-05-05 | 37.92M shares 10-Q · filed 2016-05-09 | |
| 2016-02-23 | 37.85M shares 10-K · filed 2016-02-26 | |
| 2015-11-04 | 37.64M shares 10-Q · filed 2015-11-06 | |
| 2015-08-05 | 37.44M shares 10-Q · filed 2015-08-07 | |
| 2015-05-08 | 37.30M shares 10-Q · filed 2015-05-11 | |
| 2015-02-20 | 37.22M shares 10-K · filed 2015-02-24 | |
| 2014-11-06 | 34.68M shares 10-Q · filed 2014-11-07 | |
| 2014-08-06 | 34.46M shares 10-Q · filed 2014-08-07 | |
| 2014-05-07 | 33.96M shares 10-Q · filed 2014-05-09 | |
| 2014-03-14 | 31.59M shares 10-K · filed 2014-03-18 | |
| 2013-11-01 | 31.17M shares 10-Q · filed 2013-11-07 | |
| 2013-09-01 | 31.07M shares 10-Q · filed 2013-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |